Herpes zoster associated with stroke incidence in people living with human immunodeficiency virus: a nested case-control study.
HIV
Herpes zoster
Incidence
Nested case–control study
Stroke
Taiwan National Health Insurance Research Database
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
28 Sep 2023
28 Sep 2023
Historique:
received:
25
04
2023
accepted:
19
09
2023
medline:
2
10
2023
pubmed:
29
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
The incidence of stroke is increasing among younger people with human immunodeficiency virus (HIV). The burden of stroke has shifted toward the young people living with HIV, particularly in low- and middle-income countries. People infected with herpes zoster (HZ) were more likely to suffer stroke than the general population. However, the association of HZ infection with the incidence of stroke among patients with HIV remains unclear. A nested case-control study was conducted with patients with HIV registered in the Taiwan National Health Insurance Research Database in 2000-2017. A total of 509 stroke cases were 1:10 matched to 5090 non-stroke controls on age, sex, and date of first stroke diagnosis. Logistic regression models were used to estimate the odds ratio and 95% confidence intervals (CI) of stroke incidence. The odds ratio of stroke was significantly higher in the HIV-infected population with HZ (adjusted odds ratio [AOR]: 1.85, 95% CI: 1.42-2.41). A significantly increased AOR of stroke was associated with hypertension (AOR: 3.53, 95% CI: 2.86-4.34), heart disease (AOR: 2.32, 95% CI: 1.54-3.48), chronic kidney disease (AOR: 1.82, 95% CI: 1.16-2.85), hepatitis C virus infection (AOR: 1.49, 95% CI: 1.22-1.83), hyperlipidemia (OR: 1.41, 95% CI: 1.12-1.78), and treatment with protease inhibitors (AOR: 1.33, 95% CI: 1.05-1.69). Our findings suggest that HZ concurrent with HIV may increase the risk of stroke. The incidence rates of stroke were independent of common risk factors, suggesting strategies for early prevention of HZ infection among people living with HIV.
Sections du résumé
BACKGROUND
BACKGROUND
The incidence of stroke is increasing among younger people with human immunodeficiency virus (HIV). The burden of stroke has shifted toward the young people living with HIV, particularly in low- and middle-income countries. People infected with herpes zoster (HZ) were more likely to suffer stroke than the general population. However, the association of HZ infection with the incidence of stroke among patients with HIV remains unclear.
METHODS
METHODS
A nested case-control study was conducted with patients with HIV registered in the Taiwan National Health Insurance Research Database in 2000-2017. A total of 509 stroke cases were 1:10 matched to 5090 non-stroke controls on age, sex, and date of first stroke diagnosis. Logistic regression models were used to estimate the odds ratio and 95% confidence intervals (CI) of stroke incidence.
RESULTS
RESULTS
The odds ratio of stroke was significantly higher in the HIV-infected population with HZ (adjusted odds ratio [AOR]: 1.85, 95% CI: 1.42-2.41). A significantly increased AOR of stroke was associated with hypertension (AOR: 3.53, 95% CI: 2.86-4.34), heart disease (AOR: 2.32, 95% CI: 1.54-3.48), chronic kidney disease (AOR: 1.82, 95% CI: 1.16-2.85), hepatitis C virus infection (AOR: 1.49, 95% CI: 1.22-1.83), hyperlipidemia (OR: 1.41, 95% CI: 1.12-1.78), and treatment with protease inhibitors (AOR: 1.33, 95% CI: 1.05-1.69).
CONCLUSIONS
CONCLUSIONS
Our findings suggest that HZ concurrent with HIV may increase the risk of stroke. The incidence rates of stroke were independent of common risk factors, suggesting strategies for early prevention of HZ infection among people living with HIV.
Identifiants
pubmed: 37770849
doi: 10.1186/s12879-023-08628-8
pii: 10.1186/s12879-023-08628-8
pmc: PMC10536781
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
636Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
World Health Organization. The top 10 causes of death. 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death . Accessed 20 May 2022.
Owolabi MO, Thrift AG, Mahal A, Ishida M, Martins S, Johnson WD, Pandian J, Abd-Allah F, Yaria J, Phan HT, et al. Primary stroke prevention worldwide: translating evidence into action. Lancet Public Health. 2022;7(1):e74–85.
pubmed: 34756176
Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208–11.
pubmed: 29791947
Lanas F, Seron P. Facing the stroke burden worldwide. Lancet Glob Health. 2021;9(3):e235–6.
pubmed: 33422188
Thakur KT, Boubour A, Saylor D, Das M, Bearden DR, Birbeck GL. Global HIV neurology: a comprehensive review. AIDS. 2019;33(2):163–84.
pubmed: 29547440
Benjamin LA, Corbett EL, Connor MD, Mzinganjira H, Kampondeni S, Choko A, Hopkins M, Emsley HC, Bryer A, Faragher B, et al. HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: A case-control study. Neurology. 2016;86(4):324–33.
pubmed: 26683649
pmcid: 4776088
Breuer J, Pacou M, Gautier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014;83(2):e27–33.
pubmed: 25002574
Chow FC, He W, Bacchetti P, Regan S, Feske SK, Meigs JB, Grinspoon SK, Triant VA. Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort. Neurology. 2014;83(19):1705–11.
pubmed: 25280902
pmcid: 4239837
Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr. 2012;60(4):351–8.
pubmed: 22580566
pmcid: 3670086
Marcus JL, Leyden WA, Chao CR, Chow FC, Horberg MA, Hurley LB, Klein DB, Quesenberry CP Jr, Towner WJ, Silverberg MJ. HIV infection and incidence of ischemic stroke. AIDS. 2014;28(13):1911–9.
pubmed: 24937309
Rasmussen LD, Engsig FN, Christensen H, Gerstoft J, Kronborg G, Pedersen C, Obel N. Risk of cerebrovascular events in persons with and without HIV: A Danish nationwide population-based cohort study. AIDS. 2011;25(13):1637–46.
pubmed: 21646903
Sico JJ, Chang CC, So-Armah K, Justice AC, Hylek E, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, et al. HIV status and the risk of ischemic stroke among men. Neurology. 2015;84(19):1933–40.
pubmed: 25862803
pmcid: 4433456
Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, Morabito N, Lasco A, Gangemi S, Basile G. Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity. Arch Immunol Ther Exp (Warsz). 2016;64(2):111–26.
pubmed: 26658771
Nasi M, De Biasi S, Gibellini L, Bianchini E, Pecorini S, Bacca V, Guaraldi G, Mussini C, Pinti M, Cossarizza A. Ageing and inflammation in patients with HIV infection. Clin Exp Immunol. 2017;187(1):44–52.
pubmed: 27198731
Benjamin LA, Bryer A, Emsley HC, Khoo S, Solomon T, Connor MD. HIV infection and stroke: current perspectives and future directions. Lancet Neurol. 2012;11(10):878–90.
pubmed: 22995692
pmcid: 3460367
Benjamin LA, Bryer A, Lucas S, Stanley A, Allain TJ, Joekes E, Emsley H, Turnbull I, Downey C, Toh CH, et al. Arterial ischemic stroke in HIV: defining and classifying etiology for research studies. Neurol Neuroimmunol Neuroinflamm. 2016;3(4): e254.
pubmed: 27386505
pmcid: 4929887
Hammond CK, Eley B, Wieselthaler N, Ndondo A, Wilmshurst JM. Cerebrovascular disease in children with HIV-1 infection. Dev Med Child Neurol. 2016;58(5):452–60.
pubmed: 26890389
Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci. 2014;69(7):833–42.
pubmed: 24158766
Raghavan A, Rimmelin DE, Fitch KV, Zanni MV. Sex differences in select non-communicable HIV-associated comorbidities: exploring the role of systemic immune activation/inflammation. Curr HIV/AIDS Rep. 2017;14(6):220–8.
pubmed: 29080122
pmcid: 6007989
Forbes HJ, Williamson E, Benjamin L, Breuer J, Brown MM, Langan SM, Minassian C, Smeeth L, Thomas SL, Warren-Gash C. Association of herpesviruses and stroke: systematic review and meta-analysis. PLoS ONE. 2018;13(11): e0206163.
pubmed: 30462656
pmcid: 6248930
Zhang Y, Luo G, Huang Y, Yu Q, Wang L, Li K. Risk of stroke/transient ischemic attack or myocardial infarction with herpes zoster: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2017;26(8):1807–16.
pubmed: 28501259
Hatleberg CI, Ryom L, Kamara D, De Wit S, Law M, Phillips A, Reiss P, D’Arminio Monforte A, Mocroft A, Pradier C, et al. Predictors of ischemic and hemorrhagic strokes among people living with HIV: the D:A: D International prospective multicohort study. EClinicalmedicine. 2019;13:91–100.
pubmed: 31517266
pmcid: 6737207
Silva-Pinto A, Costa A, Serrão R, Sarmento A, Abreu P. Ischaemic stroke in HIV-infected patients: A case-control study. HIV Med. 2017;18(3):214–9.
pubmed: 27535019
Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40(11):3443–8.
pubmed: 19815828
Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis. 2014;58(11):1497–503.
pubmed: 24700656
pmcid: 4017889
Asiki G, Stockdale L, Kasamba I, Vudriko T, Tumwekwase G, Johnston T, Kaleebu P, Kamali A, Seeley J, Newton R. Pilot study of antibodies against varicella zoster virus and human immunodeficiency virus in relation to the risk of developing stroke, nested within a rural cohort in Uganda. Trop Med Int Health. 2015;20(10):1306–10.
pubmed: 26083834
Patil A, Goldust M, Wollina U. Herpes zoster: A review of clinical manifestations and management. Viruses. 2022;14(2):192.
pubmed: 35215786
pmcid: 8876683
Re H-S. The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med. 1965;58(1):9–20.
Patterson BJ, Rausch DA, Irwin DE, Liang M, Yan S, Yawn BP. Analysis of vascular event risk after herpes zoster from 2007 to 2014 US insurance claims data. Mayo Clin Proc. 2019;94(5):763–75.
pubmed: 30955916
Lin LY, Warren-Gash C, Smeeth L, Chen PC. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health. 2018;40: e2018062.
pubmed: 30727703
pmcid: 6367203
Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, Lai EC. Taiwan’s National Health Insurance Research Database: past and future. Clin Epidemiol. 2019;11:349–58.
pubmed: 31118821
pmcid: 6509937
Hsieh MT, Huang KC, Hsieh CY, Tsai TT, Chen LC, Sung SF. Validation of ICD-10-CM diagnosis codes for identification of patients with acute hemorrhagic stroke in a National Health Insurance Claims Database. Clin Epidemiol. 2021;13:43–51.
pubmed: 33469381
pmcid: 7813455
Hsieh MT, Hsieh CY, Tsai TT, Wang YC, Sung SF. Performance of ICD-10-CM diagnosis codes for identifying acute ischemic stroke in a National Health Insurance Claims Database. Clin Epidemiol. 2020;12:1007–13.
pubmed: 33061648
Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4(1):1–22.
Vinikoor MJ, Napravnik S, Floris-Moore M, Wilson S, Huang DY, Eron JJ. Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. AIDS Res Hum Retroviruses. 2013;29(7):1068–74.
pubmed: 23565888
pmcid: 3685694
Chow FC, Wilson MR, Wu K, Ellis RJ, Bosch RJ, Linas BP. Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort. AIDS. 2018;32(9):1125–35.
pubmed: 29746317
Gutierrez J, Hatleberg CI, Evans H, Yin MT. Role of pre-stroke immunity in ischemic stroke mechanism among patients with HIV. AIDS Care. 2019;31(2):270–4.
pubmed: 30126294
Sundström K, Weibull CE, Söderberg-Löfdal K, Bergström T, Sparén P, Arnheim-Dahlström L. Incidence of herpes zoster and associated events including stroke—a population-based cohort study. BMC Infect Dis. 2015;15:488.
pubmed: 26520060
pmcid: 4628253
Juma K, Nyabera R, Mbugua S, Odinya G, Jowi J, Ngunga M, Zakus D, Yonga G. Cardiovascular risk factors among people living with HIV in rural Kenya: A clinic-based study. Cardiovasc J Afr. 2019;30(1):52–6.
pubmed: 30720846
Wu PH, Chuang YS, Lin YT. Does herpes zoster increase the risk of stroke and myocardial infarction? A comprehensive review. J Clin Med. 2019;8(4):547.
pubmed: 31013629
pmcid: 6518274
Nagel MA, Traktinskiy I, Azarkh Y, Kleinschmidt-DeMasters B, Hedley-Whyte T, Russman A, VanEgmond EM, Stenmark K, Frid M, Mahalingam R, et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology. 2011;77(4):364–70.
pubmed: 21753174
pmcid: 3140801
Benjamin LA, Allain TJ, Mzinganjira H, Connor MD, Smith C, Lucas S, Joekes E, Kampondeni S, Chetcuti K, Turnbull I, et al. The role of human immunodeficiency virus-associated vasculopathy in the etiology of stroke. J Infect Dis. 2017;216(5):545–53.
pubmed: 28931222
pmcid: 5853476
Erskine N, Tran H, Levin L, Ulbricht C, Fingeroth J, Kiefe C, Goldberg RJ, Singh S. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS ONE. 2017;12(7): e0181565.
pubmed: 28749981
pmcid: 5531458
Lian Y, Zhu Y, Tang F, Yang B, Duan R. Herpes zoster and the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis. PLoS ONE. 2017;12(2): e0171182.
pubmed: 28178287
pmcid: 5298244
Minassian C, Thomas SL, Smeeth L, Douglas I, Brauer R, Langan SM. Acute cardiovascular events after herpes zoster: A self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States. PLoS Med. 2015;12(12): e1001919.
pubmed: 26671338
pmcid: 4682931